Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

3 Very Oversold Dividend Stocks to Buy Right Now

Oversold dividend stocks

Why Is Novavax (NVAX) Stock Up 15% Today?

Investors in Novavax have had a very rough go over the past two years, but NVAX stock is rebounding nicely today.

NVOS Stock Alert: Novo Seeks Approval for a Reverse Stock Split

Investors in Novo Integrated Science and NVOS stock have plenty to cheer about today as the company's stock price soars 30%.

KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer

Johnson & Johnson revealed that its share exchange offer with Kenvue was oversubscribed, leading to beneficial trading for KVUE stock.

TTOO Stock Alert: T2 Biosystems Seeks Approval for Reverse Stock Split

TTOO stock investors are anticipating T2's annual meeting next month. Up for vote is a reverse stock split.

Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?

Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal.

Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?

China SXT Pharmaceuticals (SXTC) stock is rocketing higher on Monday despite a lack of news from the pharmaceutical company.

3 Under-$20 Stocks to Buy for Explosive Returns

Here are three stocks whose strategic focus and innovative progressiveness can lead to massive gains.

This F-Rated Cannabis Stock Is One of the Worst Companies You Could Buy Now

Between uncertain prospects, dilution risk, and delisting risk, I'm clearly not exaggerating when I say ACB stock is not only one of the top cannabis stocks to sell, but one of the worst stocks overall.

The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023

These are the pharma stocks to buy at undervalued levels as they represent companies investing heavily in research and development.

3 Cannabis Stocks to Snap Up Before They Skyrocket

Are you looking to invest in cannabis stocks? Here are three key players poised to capitalize on unique aspects of the cannabis market.

The 3 Most Undervalued Stocks to Buy Now: August 2023

These undervalued stocks will grow earnings over the next five years yet trade at forward price-to-earnings below 5.

CVS Stock Price Predictions: What to Know as Analysts Cut CVS Price Targets

Although a major insurer announced a reduction in reliance on CVS Health, analysts largely remain unmoved with CVS stock.

TLRY Stock Alert: Tilray Acquires Truss Beverage

Investors in Tilray and TLRY stock ought to strap in for an interesting ride on the cannabis-infused beverages train.

Why Is Aditxt (ADTX) Stock Up 10% Today?

Although Aditxt delivered a key shareholder update that boosted sentiment, ADTX stock remains a speculative venture.

Why Is Athersys (ATHX) Stock Down 36% Today?

Athersys (ATHX) stock is falling on Friday after the biotechnology company announced a $3.5 million public stock offering.

Why Is Avalo Therapeutics (AVTX) Stock Up 19% Today?

Avalo Therapeutics (AVTX) stock is rising higher on Friday with heavy trading despite a lack of news from the biotechnology company.

The 7 Most Undervalued Forever Stocks to Buy Now: August 2023

Looking for top stocks? Discover the undervalued forever stocks that can help you achieve long-term gains for your portfolio.

MRNA Stock Alert: Why Is Moderna Up 7% Today?

Investors in Moderna (MRNA) stock have received a boost today from reports that a late summer Covid wave could be on the horizon.